Akira Takahashi

7PUBLICATIONS
11CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 10, 2026
A Case of Nivolumab Efficacy in Advanced Extramammary Paget's Disease With Multiple Lymph Node Metastases.

Takuya Morioka, Yuko Kosaka, Shunichi Jinnai

|Dec 14, 2022
Updated analysis of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma.

Akira Takahashi, Kenjiro Namikawa, Dai Ogata

|Jun 21, 2021
Efficacy of surgery for skin cancers initially suspected to be carcinoma of unknown primary: a retrospective observational study.

Mao Okumura, Eiji Nakano, Kenjiro Namikawa

|Jul 30, 2020
Real-world efficacy and safety data of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma.

Akira Takahashi, Kenjiro Namikawa, Dai Ogata

|Mar 20, 2020
Hemophagocytic lymphohistiocytosis with advanced malignant melanoma accompanied by ipilimumab and nivolumab: A case report and literature review.

Haruki Mizuta, Eiji Nakano, Akira Takahashi

|Mar 13, 2020
Correlation between cutaneous adverse events and prognosis in patients with melanoma treated with nivolumab: A single institutional retrospective study.

Eiji Nakano, Akira Takahashi, Kenjiro Namikawa

Pageof 2

Frequent Collaborators

6 joint publications

Kenjiro Namikawa

6 joint publications

Naoya Yamazaki

4 joint publications

Eiji Nakano

3 joint publications

Shunichi Jinnai